Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3149 (LINC03149, also known as AC145207.5) is a non-coding RNA gene belonging to the class of long non-coding RNAs, specifically categorized as a long intergenic non-coding RNA (lincRNA)[1]. These RNAs do not overlap with protein-coding genes and generally act as RNA molecules with roles in regulation of gene expression, chromatin structure, or as molecular scaffolds[3][7]. There is no evidence from the current literature or databases that associates LINC03149 specifically with any known biological function, disease process, or therapeutic targeting. It is an approved gene symbol according to the HUGO Gene Nomenclature Committee[1]. Detailed characterization for function, disease relevance, or role as a drug target is lacking, which is common for many annotated lincRNAs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3149 (LINC03149).